Search Results - "Uemoto, Shinji"

Liver Regeneration after Hepatectomy and Partial Liver Transplantation by Yagi, Shintaro, Hirata, Masaaki, Miyachi, Yosuke, Uemoto, Shinji

“…The liver is a unique organ with an abundant regenerative capacity. Therefore, partial hepatectomy (PHx) or partial liver transplantation (PLTx) can be safely…”
Get full text

Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults by Hamaguchi, Yuhei, Kaido, Toshimi, Okumura, Shinya, Kobayashi, Atsushi, Hammad, Ahmed, Tamai, Yumiko, Inagaki, Nobuya, Uemoto, Shinji

“…Abstract Objectives Low skeletal muscle, referred to as sarcopenia, has been shown to be an independent predictor of lower overall survival in various kinds of…”
Get full text

Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study by Masui, Toshihiko, Ito, Tetsuhide, Komoto, Izumi, Uemoto, Shinji

“…The worldwide prevalence and incidence of neuroendocrine neoplasms (NEN) have been increasing recently, although few studies have analyzed data on the current…”
Get full text

Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer by Okumura, Shinya, MD, Kaido, Toshimi, MD, PhD, Hamaguchi, Yuhei, MD, Fujimoto, Yasuhiro, MD, PhD, Masui, Toshihiko, MD, PhD, Mizumoto, Masaki, MD, PhD, Hammad, Ahmed, MD, Mori, Akira, MD, PhD, Takaori, Kyoichi, MD, PhD, Uemoto, Shinji, MD, PhD

“…Background Skeletal muscle depletion, referred to as sarcopenia, is predictive of mortality in patients undergoing digestive operations. The impact of muscle…”
Get full text

Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma by Kobayashi, Atsushi, Kaido, Toshimi, Hamaguchi, Yuhei, Okumura, Shinya, Shirai, Hisaya, Yao, Siyuan, Kamo, Naoko, Yagi, Shintaro, Taura, Kojiro, Okajima, Hideaki, Uemoto, Shinji

“…OBJECTIVE:To evaluate preoperative body composition, including skeletal muscle and visceral adipose tissue, and to clarify the impact on outcomes after…”
Get full text

Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines) by Kokudo, Norihiro, Hasegawa, Kiyoshi, Akahane, Masaaki, Igaki, Hiroshi, Izumi, Namiki, Ichida, Takafumi, Uemoto, Shinji, Kaneko, Shuichi, Kawasaki, Seiji, Ku, Yonson, Kudo, Masatoshi, Kubo, Shoji, Takayama, Tadatoshi, Tateishi, Ryosuke, Fukuda, Takashi, Matsui, Osamu, Matsuyama, Yutaka, Murakami, Takamichi, Arii, Shigeki, Okazaki, Masatoshi, Makuuchi, Masatoshi

“…The 3rd version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of…”
Get full text

Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation by Hamaguchi, Yuhei, Kaido, Toshimi, Okumura, Shinya, Fujimoto, Yasuhiro, Ogawa, Kohei, Mori, Akira, Hammad, Ahmed, Tamai, Yumiko, Inagaki, Nobuya, Uemoto, Shinji

“…Intramuscular fat accumulation has come to be associated with loss of muscle strength and function, one of the components of sarcopenia. However, the impact of…”
Get full text

Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society by Umeshita, Koji, Eguchi, Susumu, Egawa, Hiroto, Haga, Hironori, Kasahara, Mureo, Kokudo, Norihiro, Sakisaka, Shotaro, Takada, Yasutsugu, Tanaka, Eiji, Eguchi, Hidetoshi, Uemoto, Shinji, Ohdan, Hideki

“…As of 31 December 2017, a total of 9242 liver transplants have been carried out in 67 institutions in Japan. There were 447 deceased donor transplants (444…”
Get full text

Management of ABO-incompatible living-donor liver transplantation: Past and present trends by Raut, Vikram, Uemoto, Shinji

“…Based on the concept that the liver is a “privileged organ,” which resists acute rejection, Thomas Starzl introduced liver transplantation across the ABO blood…”
Get full text

Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation by Hamaguchi, Yuhei, Kaido, Toshimi, Okumura, Shinya, Kobayashi, Atsushi, Shirai, Hisaya, Yagi, Shintaro, Kamo, Naoko, Okajima, Hideaki, Uemoto, Shinji

“…BACKGROUNDSkeletal muscle depletion has been shown to be an independent risk factor for poor survival in various diseases. However, in surgery, the…”
Get full text

Metronomic photodynamic therapy using an implantable LED device and orally administered 5-aminolevulinic acid by Kirino, Izumi, Fujita, Katsuhiko, Sakanoue, Kei, Sugita, Rin, Yamagishi, Kento, Takeoka, Shinji, Fujie, Toshinori, Uemoto, Shinji, Morimoto, Yuji

“…Metronomic photodynamic therapy (mPDT) is a form of PDT that induces cancer cell death by intermittent continuous irradiation with a relatively weak power of…”
Get full text

Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery by Hatano, Etsuro, Uemoto, Shinji, Yamaue, Hiroki, Yamamoto, Masakazu

“…Background The prognosis of hepatocellular carcinoma (HCC) with tumor thrombus in the major portal vein (PV) is extremely poor. The purpose of this study was…”
Get full text

Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies by Okumura, Shinya, MD, Kaido, Toshimi, MD, PhD, Hamaguchi, Yuhei, MD, Fujimoto, Yasuhiro, MD, PhD, Kobayashi, Atsushi, MD, Iida, Taku, MD, PhD, Yagi, Shintaro, MD, PhD, Taura, Kojiro, MD, PhD, Hatano, Etsuro, MD, PhD, Uemoto, Shinji, MD, PhD

“…Background Skeletal muscle depletion, referred to as sarcopenia, predicts mortality after major surgery. This study investigated the impact of preoperative…”
Get full text

Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma by Kaido, Toshimi, MD, PhD, Ogawa, Kohei, MD, PhD, Mori, Akira, MD, PhD, Fujimoto, Yasuhiro, MD, PhD, Ito, Takashi, MD, PhD, Tomiyama, Koji, MD, PhD, Takada, Yasutsugu, MD, PhD, Uemoto, Shinji, MD, PhD

“…Background Previously, we proposed expanded selection criteria for liver transplantation (LT) for hepatocellular carcinoma (HCC), the Kyoto criteria, involving…”
Get full text

Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation by Kamo, Naoko, Kaido, Toshimi, Hamaguchi, Yuhei, Okumura, Shinya, Kobayashi, Atsushi, Shirai, Hisaya, Yao, Siyuan, Yagi, Shintaro, Uemoto, Shinji

“…Sarcopenia is known to be a poor prognostic factor after liver transplantation (LT). However, the significance of obesity in combination with sarcopenia…”
Get full text

Reply to: “Predicted Volume or Actual Weight for Graft Selection Policy in Living-donor Liver Transplantation” by Kusakabe, Jiro, Yagi, Shintaro, Uemoto, Shinji

Get full text

Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma by Hamaguchi, Yuhei, Kaido, Toshimi, Okumura, Shinya, Ito, Takashi, Fujimoto, Yasuhiro, Ogawa, Kohei, Mori, Akira, Hammad, Ahmed, Hatano, Etsuro, Uemoto, Shinji

“…Background Sarcopenia has been shown to be an independent predictor of lower disease‐free and overall survival in various kinds of diseases. The quality of…”
Get full text

Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study by Yoh, Tomoaki, Cauchy, François, Le Roy, Bertrand, Seo, Satoru, Taura, Kojiro, Hobeika, Christian, Dokmak, Safi, Farges, Oliver, Gelli, Maximiliano, Sa Cunha, Antonio, Adam, René, Uemoto, Shinji, Soubrane, Olivier

“…Lymphadenectomy ensures accurate staging for patients with intrahepatic cholangiocarcinoma, especially for those without preoperatively suspected positive…”
Get full text

Optimal dosage regimen for rituximab in ABO‐incompatible living donor liver transplantation by Egawa, Hiroto, Umeshita, Koji, Uemoto, Shinji

“…Background Rituximab has greatly improved the outcomes of ABO‐incompatible living donor liver transplantation (ABO‐I LDLT). To clarify the optimal regimen for…”
Get full text

Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma by Kawai, Takayuki, Yasuchika, Kentaro, Ishii, Takamichi, Katayama, Hokahiro, Yoshitoshi, Elena Yukie, Ogiso, Satoshi, Kita, Sadahiko, Yasuda, Katsutaro, Fukumitsu, Ken, Mizumoto, Masaki, Hatano, Etsuro, Uemoto, Shinji

“…Keratin 19 (K19) is a known marker of poor prognosis and invasion in human hepatocellular carcinoma (HCC). However, the relationship between K19 and cancer…”
Get full text